GlobeNewswire Inc | Oct 28, 2021 08:00AM EDT

October 28, 2021

BRIDGEWATER, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (VYNE or the Company) today announced that it will report its financial results for the third quarter ended September 30, 2021, on Wednesday, November 10, 2021, before the market opens. VYNE will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate update.

Conference Call Details:Wednesday, November 10^th @ 8:30am Eastern TimeToll Free: 855-327-6837International: 631-891-4304Conference ID: 10017178Webcast: https://themediaframe.com/mediaframe/webcast.html?webcastid= 44cKOFEX

A replay of the call will be archived on the Companys website at www.vynetherapeutics.com after the conference call.

About VYNE Therapeutics Inc.

VYNEs mission is to improve the lives of patients by developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions. VYNE is working to develop and commercialize a variety of therapies for major immuno-inflammatory conditions and rare skin diseases with high unmet medical need. The Companys unique and proprietary pipeline includes FMX114 for the treatment of mild-to-moderate atopic dermatitis and access to a library of bromodomain & extra-terminal (BET) domain inhibitors in both topical and oral forms for the treatment of major immuno-inflammatory conditions and rare skin diseases.

For more information about VYNE Therapeutics Inc. or its investigational products, visit www.vynetherapeutics.com or follow VYNE on Twitter. VYNE may use its website to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor VYNEs website in addition to following its press releases, filings with the U.S. Securities and Exchange Commission, public conference calls, and webcasts.

Investor Relations:Joseph RanieriLifeSci Advisors, LLC617-430-7582joer@lifesciadvisors.com

Tyler ZerondaChief Financial OfficerVYNE Therapeutics908-458-9106tyler.zeronda@vynetx.com